[1]张春晓,孙秀芹*,赵考考,等.不同时期高孕激素下促排卵在高龄卵巢低反应患者助孕中的应用[J].中国计划生育和妇产科,2020,(4):59-63.
　ZHANG Chun xiao,SUN Xiu qin*,ZHAO Kao kao,et al.Application of ovulation promotion with high progestin in different periods in assisting pregnancy in elderly patients with low ovarian response[J].Chinese Journal of Family Planning & Gynecotokology,2020,(4):59-63.
点击复制

不同时期高孕激素下促排卵在高龄卵巢低反应患者助孕中的应用
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2020年4期
页码:
59-63
栏目:
论著与临床
出版日期:
2020-04-25

文章信息/Info

Title:
Application of ovulation promotion with high progestin in different periods in assisting pregnancy in elderly patients with low ovarian response
作者:
张春晓; 孙秀芹*; 赵考考; 刘思佳; 牛学英
济宁市第一人民医院生殖医学科
Author(s):
ZHANG Chunxiao; SUN Xiuqin*; ZHAO Kaokao; LIU Sijia; NIU Xueying
Department of Reproductive Medicine,Jining First Peopl's Hospital,Jining Shandong 272100,P.R.China
关键词:
卵巢低反应; PPOS方案; LPOS方案; 拮抗剂方案; 控制性超促排卵
Keywords:
poor ovarian response; PPOS protocol; LPOS protocol; antagonist protocol; controlled ovarian hyperstimulation
分类号:
R 7148
摘要:
目的　探讨卵泡期外源性高孕激素下促排卵（progestinprimed ovarian stimulation，PPOS）方案、黄体期内源性高孕激素下促排卵（lutealphase ovarian stimulation，LPOS）方案和拮抗剂方案在高龄卵巢低反应（poor ovarian response,POR）患者体外受精/卵母细胞质内单精子注射胚胎移植（in vitro fertilization/ intracytoplasmic sperm injectionembryo transfer,IVF/ICSIET）助孕中的临床应用。方法　回顾性分析2015年1月至2019年6月于济宁市第一人民医院生殖医学科行IVF/ICSIET助孕的高龄POR患者224个控制性超促排卵（controlled ovarian hyperstimulation,COH）周期的临床资料，根据促排方案不同分为3组，分别为A组（拮抗剂方案，88个周期）、B组（PPOS方案，61个周期）、C组（LPOS方案，75个周期），观察3组患者的助孕效果。结果　① A、B、C组患者年龄［（3965±273）岁、（4016±275）岁、（3989±330）岁］、不孕年限［（340±218）年、（392±208）年、333±223）年］比较，差异无统计学意义（P>005）。② 3组患者周期临床资料比较：A、B、C组患者外源性促性腺激素（gonadotropin,Gn）使用总量［（2 12416±59044）U、（2 07557±59218）U、（1 99367±55660）U］、Gn使用时间［（899±269）d、（877±247）d、817±223）d］比较差异无统计学意义（P>005）；A组人绒毛膜促性腺激素（human chorionic gonadotropin，hCG）日雌二醇（estradiol，E2）水平［（3 40438±1 27694）pmol/L］、hCG日优势卵泡数［（309±123）个］、卵泡输出率（follicular output rate,FORT）（6634 %）均小于Ｂ组［（4 08566±1 03377） pmol/L、（370±142）个、8188 %］和Ｃ组［（ 3 95449±1 15074）pmol/L、（364±154）个、8101 %］，差异有统计学意义（P<005）；A组早发黄体生成素（luteinizing hormone，LH）峰率（682 %）大于B、C组（164 %、0），差异有统计学意义（P<005）；上述临床资料B组与C组比较，差异无统计学意义（P>005）。③ 3组患者实验室指标比较：A组获卵数（88个）多于B、C组（61个、75个）（P<005）；3组患者成熟卵率（8527 %、8618 %、8556 %）、ICSI率（1589 %、1705 %、1630 %）、2PN受精率（7209 %、7419 %、7519 %）比较差异均无统计学意义（P>005）；A组卵裂数［（231±102）个］、可利用胚胎数［（163±086）个］、优质胚胎数［（116±078）个］均少于Ｂ组［（279±125）个、（207±098）个、（157±074）个］和Ｃ组［（285±129）个、（211±099）个、（153±079）个）］，周期取消率（2159 %）大于B、C组（820 %、933 %），差异均有统计学意义（P<005），上述实验室指标B组与C组比较，差异无统计学意义（P>005）。结论　在高龄POR患者COH周期中，PPOS方案与LPOS方案有相近的促排疗效；与拮抗剂方案相比，PPOS及LPOS方案均能提高高龄POR患者FORT、有效预防早发LH峰、降低周期取消率，获得更多的优质胚胎，提示PPOS及LPOS方案是高龄POR患者理想的COH方案。
Abstract:
ObjectiveTo explore the progestinprimed ovarian stimulation(PPOS) scheme in the follicular phase, the lutealphase ovarian stimulation(LPOS) scheme and the antagonist scheme in the advanced age clinical application of in vitro fertilization/intracytoplasmic sperm injectionembryo transfer (IVF/ICSIET) to assist pregnancy in patients with poor ovarian response (POR).MethodsRetrospective analysis of 224 controlled ovarian hyperstimulation (COH) cycles in elderly POR patients who underwent IVF/ICSIET assisted pregnancy in the Department of Reproductive Medicine of Jining First People's Hospital from January 2015 to June 2019. The clinical data was divided into 3 groups according to different types of promotion schedules: group A (antagonist program, 88 cycles), group B (PPOS program, 61 cycles), and group C (LPOS program, 75 cycles). Observe the effect of assisting pregnancy in 3 groups of patients. Results ① The age of patients in groups A, B, and C was ［(3965 ± 273) years, (4016 ± 275) years, (3989 ± 330) years］, infertility years ［(340 ± 218) years, (392 ± 208) years， （333 ± 223) years］, the differences were not statistically significant (P> 005). ② Comparison of clinical data of three groups of patients: The total amount of gonadotropin (Gn) used by patients in groups A, B, and C ［(2 12416 ± 59044) U, (2 07557 ± 59218) U, (1 99367 ± 55660) U］, Gn use time ［(899 ± 269) d, (877 ± 247) d, （817 ± 223) d］ were compared,there were no statistically significant differences (P> 005); Estradiol (E2) level of human chorionic gonadotropin(hCG) day［(3 40438 ± 1 27694) pmol/L］, number of dominant follicles of hCG day ［(309 ± 123)］, follicular output rate(FORT) (6634 %) in group A were less than group B ［(4 08566 ± 1 03377) pmol/L, (370 ± 142), 8188 %］ and group C ［(3 95449 ± 1 15074) pmol/L, (364 ± 154), 8101 %］, the differences were statistically significant (P<005); the peak rate of early luteinizing hormone (LH) in group A (682 %) was greater than that in groups B and C (164 %, 0) the difference was statistically significant (P<005); there was no significant difference between group B and group C in the above clinical data (P>005). ③ Comparison of laboratory indexes of the three groups of patients: The number of eggs obtained in group A (88) was less than that in groups B and C (61, 75) (P<005); the mature egg rate of the three groups of patients (8527 %, 8618 %, 8556 %), ICSI rate (1589 %, 1705 %, 1630 %), 2PN fertilization rates (7209 %, 7419 %, 7519 %) were not statistically significant (P>005); the number of cleavages in group A (231 ± 102), available embryos (163 ± 086), highquality embryos (116 ± 078) were less than group B ［(279 ± 125), (207 ± 098), (157 ± 074)］ and group C ［(285 ± 129), (211 ± 099), (153 ± 079)］, the cycle cancellation rate (2159 %) was greater than that of group B and C (820 %, 933 %), the differences were statistically significant (P<005). There was no statistically significant difference between the above laboratory indicators in group B and group C (P> 005). Conclusion In the COH cycle of elderly POR patients, PPOS and LPOS have similar effects in promoting elimination; compared with antagonists program, both PPOS and LPOS can improve the FORT of elderly POR patients and effectively prevent early onset. LH peak, lower cycle cancellation rate, and obtain more highquality embryos, suggesting that PPOS and LPOS schemes are ideal COH schemes for elderly POR patients.

参考文献/References:

［1］武学清，孔蕊，田莉，等．卵巢低反应专家共识 ［J］．生殖与避孕，2015，35（2）：7179． ［2］Ferraretti A P, La Marca A, Fauser B C, et al.ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria ［J］.Human Reproduction （Oxford, England）, 2011, 26（7）: 16161624. ［3］Brinsden　PR．全松,陈雷宁译.体外受精与辅助生殖:Bourn Hall诊所临床实践与实验室操作指南 ［M］．北京：人民卫生出版社，2009：233234． ［4］叶虹．高黄体生成素水平与早发黄体生成素峰的概念 ［J］．生殖医学杂志，2010，19（3）：177179． ［5］邢阿英，王大琳，耿蒙慧，等．控制性超促排卵过程中评估卵巢敏感性的新指标 ［J］．中华生殖与避孕杂志，2018，38（12）：10281031． ［6］蒋励，陈耀龙，罗旭飞，等．中国高龄不孕女性辅助生殖临床实践指南 ［J］．中国循证医学杂志，2019，19（3）：253270． ［7］Ubaldif F, Vaiarelli A, D'Anna R, et al.Management of poor responders in IVF:Is there anything new?［J］.BioMed Research International, 2014, 14（1）:110. ［8］Revelli A, Biasoni V, Gennarelli G A, et al.IVF results in patients with very low serum AMH are significantly affected by chronological age ［J］.Journal of Assisted Reproduction and Genetics, 2016, 33（5）: 603609. ［9］Martinez F, Barri P N, Coroleu B, et al.Women with poor response to IVF have lowered circulating gonadotrophin surgeattenuating factor（GnSAF）bioactivity during spontaneous and stimulated cycles ［J］.Repro, 2002, 17（3）: 634640. ［10］奚倩雯，匡延平．高孕激素状态下促排卵——一种新的促排卵方案 ［J］．中华生殖与避孕杂志，2018，38（2）：147151． ［11］Bar Hava I, Blueshtein M, Ganer Herman H, et al.Gonadotropinreleasing hormone analogue as sole luteal support in antagonistbased assisted reproductive technology cycles ［J］.Fertility and Sterility, 2017, 107（1）: 130135.e1. ［12］齐诠，黄莉，李子涛，等．年轻POR女性拮抗剂方案与长方案的新鲜移植周期临床妊娠结局的比较分析 ［J］．现代生物医学进展，2018，18（14）：27092713． ［13］Wang Ruolin, Lin Shouren, Wang Yong, et al.Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and metaanalysis ［J］.PLOS One, 2017, 12（4）: e 0175985. ［14］张丽娜，孙克，纪亚忠．卵巢功能下降的评估标准及其诊治进展 ［J］．第二军医大学学报，2019，40（6）：659663． ［15］Bosch E, Valencia W, Escudero E, et al.Premature luteinization during gonadotropinreleasing hormone antagonist cycles and its relationship with in vitro fertilization outcome ［J］.Fertility and Sterility, 2003, 80（6）: 14441449. ［16］Kuang Yanping, Chen Qiuju, Fu Yonglun, et al.Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization ［J］.Fertility and Sterility, 2015, 104（1）: 6270.e 3. ［17］He Wen, Li Xiaofeng, Adekunbi D, et al.Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinising hormone in female rats ［J］.Scientific Reports, 2017, 7（1）: 8096. ［18］Massin N.New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF ［J］.Human Reproduction Update, 2017, 23（2）: 211220. ［19］Chen Hong, Wang Yun, Lyu Q, et al.Comparison of livebirth defects after lutealphase ovarian stimulation vs.conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles ［J］.Fertility and Sterility, 2015, 103（5）: 1194. ［20］杨榃楚，陈豪英，习海涛，等．两种高孕激素状态下促排方案在卵巢低反应患者中的应用比较 ［J］．浙江医学，2018，40（24）：26422646． ［21］张楚，黄晓洁．卵泡期高孕激素状态下促排卵方案的研究进展 ［J］．医药导报，2019，38（8）：10431047．

相似文献/References:

[1]黄卡立,公方强,檀大羡,等.应用微刺激联合拮抗剂方案对76例卵巢低反应者进行体外受精-胚胎移植的临床研究[J].中国计划生育和妇产科,2010,(01):0.
　HUANG Ka-li,GONG Fang-qiang,TAN Da-xianResearch centre of population and family planning of Guangxi Zhuang Autonomous Region,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(4):0.
[2]刘芳,陈秀娟,赵杰,等.脱氢表雄酮联合微刺激方案在卵巢低反应体外受精-胚胎移植中的治疗效果[J].中国计划生育和妇产科,2016,(03):0.
　LIU Fang,CHEN Xiu-juan,ZHAO Jie,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(4):0.
[3]刘明慧,李媛.体外受精/单精子卵母细胞内注射治疗周期中高龄患者受精方式选择的研究进展[J].中国计划生育和妇产科,2016,(11):0.
[4]赵燕*,薛萍萍,姜宙,等.睾丸酮用于卵巢低反应患者辅助生殖治疗的 荟萃分析[J].中国计划生育和妇产科,2019,(1):34.
　ZHAO Yan*,XUE Ping-ping,JIANG Zhou,et al.Testosterone pretreatment in poor responders undergoing ART: a systematic meta-analysis[J].Chinese Journal of Family Planning & Gynecotokology,2019,(4):34.

更新日期/Last Update: 2020-04-25